We are live on ! Find out more
PKBO

Peak Bio, Inc. Common Stock
PKBO

Delisted

PKBO was delisted on the 9th of January, 2023.

Back to rankings

30 hedge funds and large institutions have $33.4M invested in Peak Bio, Inc. Common Stock in 2021 Q3 according to their latest regulatory filings, with 8 funds opening new positions, 8 increasing their positions, 2 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

300% more first-time investments, than exits

New positions opened: 8 | Existing positions closed: 2

300% more repeat investments, than reductions

Existing positions increased: 8 | Existing positions reduced: 2

52% more capital invested

Capital invested by funds: $21.9M → $33.4M (+$11.5M)

25% more funds holding

Funds holding: 24 → 30 (+6)

Holders
30
Holders Change
+6
Holders Change %
+25%
% of All Funds
0.53%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
8
Increased
8
Reduced
2
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
DM
Deerfield Management
New York
+$7.03M
2
WRBC
W.R. Berkley Corp
Connecticut
+$1.11M
3
KPF
K2 Principal Fund
Ontario, Canada
+$663K
4
DKCM
Davidson Kempner Capital Management
New York
+$475K
5
PMAM
Picton Mahoney Asset Management
Ontario, Canada
+$388K

Top Sellers

Rank Fund Capital Flow
1
MP
Mangrove Partners
Connecticut
-$1.23M
2
KIM
Karpus Investment Management
New York
-$95.1K
3
Citadel Advisors
Citadel Advisors
Florida
-$36.1K
4
PAM
Panagora Asset Management
Massachusetts
-$18K
Name Holding Trade Value Shares
Change 		Change in
Stake
DM
1
Deerfield Management
New York
$7.1M +$7.03M +725,000 New
KPF
2
K2 Principal Fund
Ontario, Canada
$4.04M +$663K +68,323 +20%
DKCM
3
Davidson Kempner Capital Management
New York
$2.2M +$475K +49,020 +28%
SCM
4
Saba Capital Management
New York
$2.18M – – –
Hudson Bay Capital Management
5
Hudson Bay Capital Management
Connecticut
$1.96M – – –
WRBC
6
W.R. Berkley Corp
Connecticut
$1.96M +$1.11M +114,744 New
KIM
7
Karpus Investment Management
New York
$1.53M -$95.1K -9,800 -6%
PC
8
Periscope Capital
Ontario, Canada
$1.47M – – –
BCM
9
Basso Capital Management
Connecticut
$1.12M +$118K +12,210 +12%
Citadel Advisors
10
Citadel Advisors
Florida
$1.09M -$36.1K -3,725 -3%
BFM
11
Boothbay Fund Management
New York
$991K – – –
ASM
12
ATW SPAC Management
New York
$979K – – –
RCM
13
Radcliffe Capital Management
Pennsylvania
$979K – – –
PAMP
14
Polar Asset Management Partners
Ontario, Canada
$734K – – –
CM
15
Cohanzick Management
New York
$722K +$226K +23,337 +46%
Jane Street
16
Jane Street
New York
$561K +$1.94K +200 +0.4%
Millennium Management
17
Millennium Management
New York
$483K +$121K +12,500 +34%
WAM
18
Wolverine Asset Management
Illinois
$409K +$361K +37,168 +804%
CH
19
CVI Holdings
Delaware
$392K – – –
PMAM
20
Picton Mahoney Asset Management
Ontario, Canada
$392K +$388K +40,000 New
LCM
21
Landscape Capital Management
New Jersey
$360K +$35.3K +3,634 +11%
DFCM
22
Dark Forest Capital Management
Puerto Rico
$345K +$342K +35,216 New
D.E. Shaw & Co
23
D.E. Shaw & Co
New York
$337K +$334K +34,399 New
BI
24
Bulldog Investors
New Jersey
$245K – – –
Goldman Sachs
25
Goldman Sachs
New York
$236K +$234K +24,152 New
1
2

PKBO Hedge Fund Activity: Q3 2021 in Review

30 of the 5,712 institutional investors tracked by Wall St. Rank reported a position in Peak Bio, Inc. Common Stock (PKBO) for Q3 2021, worth a combined $33.4M — up 52% from $21.9M a quarter earlier.

Buyers outnumbered sellers: 8 funds opened new PKBO positions and 2 closed out — a net gain of 6 holders — while 8 added to existing stakes and 2 trimmed.

The largest buyer was Deerfield Management, opening a new position worth an estimated $7.03M. The largest seller was Mangrove Partners, exiting entirely with an estimated $1.23M sold.

  • 30 institutional investors held Peak Bio, Inc. Common Stock (PKBO) as of Q3 2021, up from 24 in Q2 2021.
  • Funds reported $33.4M of Peak Bio, Inc. Common Stock stock for Q3 2021, up 52% quarter-over-quarter.
  • 8 funds opened new Peak Bio, Inc. Common Stock positions in Q3 2021 and 2 closed out, a net change of +6 holders.
  • The largest Peak Bio, Inc. Common Stock buyer in Q3 2021 was Deerfield Management, an estimated $7.03M added.
  • The largest Peak Bio, Inc. Common Stock seller in Q3 2021 was Mangrove Partners, an estimated $1.23M sold.

Based on aggregated 13F filings for Q3 2021.